Freestone Grove Partners LP Vericel Corp Transaction History
Freestone Grove Partners LP
- $13.4 Trillion
- Q3 2025
A detailed history of Freestone Grove Partners LP transactions in Vericel Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 18,382 shares of VCEL stock, worth $732,706. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,382Holding current value
$732,706% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
278Shares Held
51.3MCall Options Held
15.2KPut Options Held
9.1K-
Black Rock Inc. New York, NY8.06MShares$321 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$140 Million0.0% of portfolio
-
State Street Corp Boston, MA2.81MShares$112 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.21MShares$88.1 Million0.19% of portfolio
-
Conestoga Capital Advisors, LLC2.18MShares$86.7 Million1.1% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.88B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...